JA(c)K-in-the-platelet and M(i)PL Fetch PF4

Overview

Journal Blood

Publisher Elsevier

Specialty Hematology

Date 2024 Jan 4

PMID 38175681

Authors

Sally Thomas

Anandi Krishnan

Affiliations

Soon will be listed here.

References

How J, Garcia J, Mullally A . Biology and therapeutic targeting of molecular mechanisms in MPNs. Blood. 2022; 141(16):1922-1933. PMC: 10163317. DOI: 10.1182/blood.2022017416. View

Cui L, Moraga I, Lerbs T, Van Neste C, Wilmes S, Tsutsumi N . Tuning MPL signaling to influence hematopoietic stem cell differentiation and inhibit essential thrombocythemia progenitors. Proc Natl Acad Sci U S A. 2021; 118(2). PMC: 7812794. DOI: 10.1073/pnas.2017849118. View

Buka R, Montague S, Moran L, Martin E, Slater A, Watson S . PF4 activates the c-Mpl-Jak2 pathway in platelets. Blood. 2023; 143(1):64-69. PMC: 10862235. DOI: 10.1182/blood.2023020872. View

Schroer A, Ventura P, Sucharov J, Misra R, Chui M, Bieri G . Platelet factors attenuate inflammation and rescue cognition in ageing. Nature. 2023; 620(7976):1071-1079. PMC: 10468395. DOI: 10.1038/s41586-023-06436-3. View

Setyawan J, Azimi N, Strand V, Yarur A, Fridman M . Reporting of Thromboembolic Events with JAK Inhibitors: Analysis of the FAERS Database 2010-2019. Drug Saf. 2021; 44(8):889-897. PMC: 8280037. DOI: 10.1007/s40264-021-01082-y. View

Ott N, Faletti L, Heeg M, Andreani V, Grimbacher B . JAKs and STATs from a Clinical Perspective: Loss-of-Function Mutations, Gain-of-Function Mutations, and Their Multidimensional Consequences. J Clin Immunol. 2023; 43(6):1326-1359. PMC: 10354173. DOI: 10.1007/s10875-023-01483-x. View

Ezumi Y, Takayama H, Okuma M . Thrombopoietin, c-Mpl ligand, induces tyrosine phosphorylation of Tyk2, JAK2, and STAT3, and enhances agonists-induced aggregation in platelets in vitro. FEBS Lett. 1995; 374(1):48-52. DOI: 10.1016/0014-5793(95)01072-m. View

Lambert M, Wang Y, Bdeir K, Nguyen Y, Kowalska M, Poncz M . Platelet factor 4 regulates megakaryopoiesis through low-density lipoprotein receptor-related protein 1 (LRP1) on megakaryocytes. Blood. 2009; 114(11):2290-8. PMC: 2745847. DOI: 10.1182/blood-2009-04-216473. View

Shen Z, Du W, Perkins C, Fechter L, Natu V, Maecker H . Platelet transcriptome identifies progressive markers and potential therapeutic targets in chronic myeloproliferative neoplasms. Cell Rep Med. 2021; 2(10):100425. PMC: 8561315. DOI: 10.1016/j.xcrm.2021.100425. View

10.

Selvadurai M, Favaloro E, Chen V . Mechanisms of Thrombosis in Heparin-Induced Thrombocytopenia and Vaccine-Induced Immune Thrombotic Thrombocytopenia. Semin Thromb Hemost. 2023; 49(5):444-452. DOI: 10.1055/s-0043-1761269. View